2017 -2021 Acting Chief Medical Officer @ Peptilogics
2021 -2021 Acting Chief Medical Officer @
2018 -2021 Chief Medical Officer @ CytoAgents.com
2020 -2021 Acting Chief Medical Officer @ Filtricine
2019 -2019 Clinical Development Consultant @ Tolerion
now Clinical Development Consultant @ Western Oncolytics Ltd.
2017 -2017 Clinical Development Consultant @ Nuredis
2017 -2017 Acting Chief Medical Officer @ Peptilogics
now Consultant @ Stanford SPARK
2011 -2014 Senior Vice President, Clinical Development and Scientific Licensing @
2009 -2011 Clinical Development Consultant @
2008 -2009 Chief Medical Officer @
2006 -2008 Vice President, CV Development @
now Clinical Consultant @ Portola Pharmaceuticals, Inc
now Clinical Consultant @ Arete Therapeutics
now Chief Medical Officer @ Orexigen
now Chief Medical Officer @ Corgentech
now VP Medical Affairs @ Cor Therapeutics Inc.
now Clinical Research @ Xoma
Todd Lorenz Education
Case Western Reserve University School of Medicine
MD (Medicine)
1975-1979
Todd Lorenz Skills
Project Management
Leadership
Medical Devices
Hematology
Medical Affairs
Immunology
Inflammation
Clinical Development
Start Ups
Strategic Planning
Clinical Research
Management
Business Analysis
Clinical Trials
Drug Development
Customer Service
Drug Discovery
Oncology
CRO
Medicine
Cardiology
Endocrinology
Cardiovascular
Healthcare
Biotechnology
Biopharmaceuticals
Todd Lorenz Summary
Todd Lorenz, based in Orinda, CA, US, is currently a Interim Chief Executive Officer at Abscopal Therapeutics. Todd Lorenz brings experience from previous roles at UC Riverside, Novasenta, Immunome, Inc. and Nimbus Therapeutics. Todd Lorenz holds a 1975 - 1979 MD in Medicine @ Case Western Reserve University School of Medicine. With a robust skill set that includes Project Management, Leadership, Medical Devices, Hematology, Medical Affairs and more. Todd Lorenz has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Todd Lorenz?
Find contact details for 700 million professionals.